| Identification | Back Directory | [Name]
Methyl 6-azido-6-deoxy-alpha-D-glucopyranoside | [CAS]
23701-87-3 | [Synonyms]
Methyl 6-Azido-6-deoxy-α-D-glucopyranoside
Methyl 6-Azido-6-deoxy-α-D-glucopyranoside
Methyl 6-azido-6-deoxy- a-D-glucopyranoside
6-azido-6-deoxy-1-O-Methyl-α-D-glucopyranose
6-azido-6-deoxy-1-O-Methyl-α-D-glucopyranose
METHYL 6-AZIDO-6-DEOXY-ALPHA-D-GLUCOPYRANOSIDE | [Molecular Formula]
C7H13N3O5 | [MOL File]
23701-87-3.mol | [Molecular Weight]
219.2 |
| Chemical Properties | Back Directory | [Melting point ]
102-104 °C | [storage temp. ]
-20°C Freezer | [solubility ]
Dichloromethane; Ethyl Acetate; Methanol | [form ]
Light Yellow Oild |
| Hazard Information | Back Directory | [Uses]
Methyl 6-Azido-6-deoxy-α-D-glucopyranoside is an intermediate in synthesizing Ranimustine (R120030), a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera. It can be used in biological study of synthesis of anti-EGFR antibody-drug conjugates. It can also be used in therapeutic use and biological study of BCMA (B-Cell Maturation Antigen) antigen binding proteins. |
|
|